Burckhardt Compression Holding Valuation
Is BCHN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BCHN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BCHN (CHF613) is trading below our estimate of fair value (CHF864.61)
Significantly Below Fair Value: BCHN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BCHN?
Other financial metrics that can be useful for relative valuation.
| What is BCHN's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CHF 2.08b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.2x |
| Enterprise Value/EBITDA | 14.4x |
| PEG Ratio | 2.6x |
Price to Earnings Ratio vs Peers
How does BCHN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 29.5x | ||
KARN Kardex Holding | 31.4x | 6.0% | CHF 2.1b |
DAE Dätwyler Holding | 36.4x | 27.4% | CHF 2.7b |
INRN Interroll Holding | 30.2x | 11.1% | CHF 2.1b |
SFSN SFS Group | 20.1x | 10.0% | CHF 5.1b |
BCHN Burckhardt Compression Holding | 23.1x | 9.0% | CHF 2.1b |
Price-To-Earnings vs Peers: BCHN is good value based on its Price-To-Earnings Ratio (23.1x) compared to the peer average (29.5x).
Price to Earnings Ratio vs Industry
How does BCHN's PE Ratio compare vs other companies in the European Machinery Industry?
Price-To-Earnings vs Industry: BCHN is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the European Machinery industry average (17.8x).
Price to Earnings Ratio vs Fair Ratio
What is BCHN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 23.1x |
| Fair PE Ratio | 20x |
Price-To-Earnings vs Fair Ratio: BCHN is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the estimated Fair Price-To-Earnings Ratio (20x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 613.00 | CHF 648.20 +5.7% | 10.1% | CHF 750.00 | CHF 579.00 | n/a | 5 |
| Oct ’25 | CHF 597.00 | CHF 657.25 +10.1% | 10.7% | CHF 750.00 | CHF 579.00 | n/a | 4 |
| Sep ’25 | CHF 603.00 | CHF 657.25 +9.0% | 10.7% | CHF 750.00 | CHF 579.00 | n/a | 4 |
| Aug ’25 | CHF 613.00 | CHF 657.25 +7.2% | 10.7% | CHF 750.00 | CHF 579.00 | n/a | 4 |
| Jul ’25 | CHF 596.00 | CHF 639.75 +7.3% | 10.3% | CHF 750.00 | CHF 579.00 | n/a | 4 |
| Jun ’25 | CHF 603.00 | CHF 604.50 +0.2% | 6.0% | CHF 650.00 | CHF 568.00 | n/a | 4 |
| May ’25 | CHF 586.00 | CHF 604.50 +3.2% | 6.0% | CHF 650.00 | CHF 568.00 | n/a | 4 |
| Apr ’25 | CHF 565.00 | CHF 604.50 +7.0% | 6.0% | CHF 650.00 | CHF 568.00 | n/a | 4 |
| Mar ’25 | CHF 528.00 | CHF 604.50 +14.5% | 6.0% | CHF 650.00 | CHF 568.00 | n/a | 4 |
| Feb ’25 | CHF 485.50 | CHF 596.00 +22.8% | 6.4% | CHF 650.00 | CHF 568.00 | n/a | 3 |
| Jan ’25 | CHF 507.00 | CHF 604.50 +19.2% | 6.0% | CHF 650.00 | CHF 568.00 | n/a | 4 |
| Dec ’24 | CHF 485.50 | CHF 604.50 +24.5% | 6.0% | CHF 650.00 | CHF 568.00 | n/a | 4 |
| Nov ’24 | CHF 457.00 | CHF 604.50 +32.3% | 6.0% | CHF 650.00 | CHF 568.00 | n/a | 4 |
| Oct ’24 | CHF 499.50 | CHF 604.50 +21.0% | 6.0% | CHF 650.00 | CHF 568.00 | CHF 597.00 | 4 |
| Sep ’24 | CHF 528.00 | CHF 609.60 +15.5% | 5.6% | CHF 650.00 | CHF 568.00 | CHF 603.00 | 5 |
| Aug ’24 | CHF 513.00 | CHF 589.60 +14.9% | 5.7% | CHF 630.00 | CHF 550.00 | CHF 613.00 | 5 |
| Jul ’24 | CHF 525.00 | CHF 589.60 +12.3% | 5.7% | CHF 630.00 | CHF 550.00 | CHF 596.00 | 5 |
| Jun ’24 | CHF 541.00 | CHF 587.60 +8.6% | 5.4% | CHF 630.00 | CHF 550.00 | CHF 603.00 | 5 |
| May ’24 | CHF 550.00 | CHF 553.60 +0.7% | 9.8% | CHF 630.00 | CHF 460.00 | CHF 586.00 | 5 |
| Apr ’24 | CHF 568.00 | CHF 553.60 -2.5% | 9.8% | CHF 630.00 | CHF 460.00 | CHF 565.00 | 5 |
| Mar ’24 | CHF 570.00 | CHF 540.80 -5.1% | 7.6% | CHF 568.00 | CHF 460.00 | CHF 528.00 | 5 |
| Feb ’24 | CHF 564.00 | CHF 540.80 -4.1% | 7.6% | CHF 568.00 | CHF 460.00 | CHF 485.50 | 5 |
| Jan ’24 | CHF 551.00 | CHF 521.20 -5.4% | 8.9% | CHF 566.00 | CHF 460.00 | CHF 507.00 | 5 |
| Dec ’23 | CHF 532.00 | CHF 521.20 -2.0% | 8.9% | CHF 566.00 | CHF 460.00 | CHF 485.50 | 5 |
| Nov ’23 | CHF 482.50 | CHF 508.00 +5.3% | 8.6% | CHF 580.00 | CHF 460.00 | CHF 457.00 | 5 |
| Oct ’23 | CHF 371.00 | CHF 508.00 +36.9% | 8.6% | CHF 580.00 | CHF 460.00 | CHF 499.50 | 5 |
Analyst Forecast: Target price is less than 20% higher than the current share price.